<p>根據公司在最近向證券交易委員會的披露，Federated Hermes Inc. 在第二季度將其在 Revvity Inc.（紐約證券交易所代碼：RVTY - 免費報告）中的股份減少了 9.5%。該機構投資者在此期間出售了 22,482 股後，持有 213,182 股該公司的股票。截至其最近向證券交易委員會的備案，Federated Hermes Inc. 持有 Revvity 約 0.18% 的股份，價值 20,619,000 美元。</p>
<p>其他機構投資者和對沖基金最近也增加或減少了對該公司的持股。凱通國際資產管理有限公司在第一季度將其在 Revvity 的持股增加了 25.3%。凱通國際資產管理有限公司目前持有 694 股該公司的股票，價值 73,000 美元，此前在上個季度又購買了 140 股。跨大西洋銀行在第一季度將其在 Revvity 的持股增加了 19.4%。跨大西洋銀行目前持有 925 股該公司的股票，價值 90,000 美元，此前在此期間又收購了 150 股。CVA Family Office LLC 在第二季度將其在 Revvity 的持股增加了 79.0%。CVA Family Office LLC 目前持有 410 股該公司的股票，價值 40,000 美元，此前在上個季度又購買了 181 股。EverSource Wealth Advisors LLC 在第二季度將其在 Revvity 的持股增加了 25.9%。EverSource Wealth Advisors LLC 目前持有 900 股該公司的股票，價值 87,000 美元，此前在上個季度又購買了 185 股。最後，Leslie Global Wealth LLC 在第二季度將其在 Revvity 的持股增加了 9.3%。Leslie Global Wealth LLC 目前持有 2,195 股該公司的股票，價值 212,000 美元，此前在上個季度又購買了 186 股。目前 86.65% 的股票由機構投資者和對沖基金持有。</p>
<h2>分析師評級調整</h2>
<p>幾家研究公司對 RVTY 發表了看法。巴克萊將 Revvity 的目標價格從 100.00 美元上調至 105.00 美元，並在 10 月 28 日的報告中給予該公司 “超配” 評級。Weiss Ratings 在週一的研究報告中重新發布了對 Revvity 股票的 “賣出（d）” 評級。美國銀行在 9 月 22 日的研究報告中將 Revvity 的目標價格從 110.00 美元下調至 99.00 美元，併為該公司設定了 “買入” 評級。羅伯特·W·貝爾德在 10 月 28 日的研究報告中將 Revvity 的目標價格從 122.00 美元上調至 123.00 美元，並給予該公司 “跑贏大盤” 評級。最後，Evercore ISI 在 10 月 27 日的研究報告中重新發布了 “跑贏大盤” 評級，併為 Revvity 設定了 108.00 美元的目標價格。七位股票研究分析師對該股票給予了買入評級，六位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “持有”，平均目標價格為 113.08 美元。</p>
<p><strong>查看我們最新的 RVTY 股票分析</strong></p>
<h2>Revvity 價格表現</h2>
<p>Revvity 股票在週三開盤價為 98.85 美元。該公司的市值為 112.1 億美元，市盈率為 49.67，市盈增長比率為 3.30，貝塔值為 1.06。Revvity Inc.的 12 個月最低價為 81.36 美元，最高價為 128.29 美元。該公司的債務與股本比率為 0.36，流動比率為 1.75，速動比率為 1.44。該公司的 50 日移動平均線為 95.54 美元，200 日移動平均線為 93.12 美元。</p>
<p>Revvity（紐約證券交易所代碼：RVTY - 獲取免費報告）最近在 10 月 27 日發佈了季度財報。該公司報告本季度每股收益為 1.18 美元，超出分析師共識預期的 1.14 美元，超出幅度為 0.04 美元。Revvity 的淨利潤率為 8.44%，股本回報率為 7.52%。該公司在本季度的收入為 6.9895 億美元，而分析師預期為 6.9975 億美元。在去年同期，該公司每股收益為 1.28 美元。該公司的收入同比增長了 2.2%。Revvity 已將其 2025 財年的指導目標設定為 4.900-5.000 每股收益。股票分析師預測 Revvity Inc.在當前年度將發佈 4.94 美元的每股收益。</p>
<h2>Revvity 股息公告</h2>
<p>該公司最近還披露了一項季度股息，將於 2 月 6 日（星期五）支付。1 月 16 日（星期五）登記的股東將獲得每股 0.07 美元的股息。除息日期為 1 月 16 日（星期五）。這代表着每年 0.28 美元的股息和 0.3% 的股息收益率。Revvity 的股息支付比率（DPR）為 14.07%。</p>
<p>Revvity 宣佈其董事會已於 10 月 27 日批准了一項股票回購計劃，允許公司回購 10 億美元的股票。該回購授權允許公司通過公開市場購買最多 8.7% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
<h2>Revvity 公司簡介</h2>
<p>（免費報告）</p>
<p>Revvity, Inc.在美洲、歐洲和亞洲及國際上提供健康科學解決方案、技術和服務。生命科學部門提供儀器、試劑、信息學、軟件、訂閲、檢測、成像技術、保修、培訓和服務。其診斷部門提供儀器、試劑、檢測平台和軟件產品，用於早期檢測遺傳疾病，如妊娠和早期兒童疾病，以及在診斷市場中的傳染病檢測。</p>
<h2>特色文章</h2>
<ul>
<li>我們更看好的五隻股票比 Revvity 更好</li>
<li>成長股：它們是什麼，例子以及如何投資</li>
<li>消費者得到了煤炭，但聖誕老人給這兩家零售商帶來了巨大的收益</li>
<li>稀釋每股收益（Diluted EPS）是什麼？</li>
<li>10 倍收益？這三隻機器人股票可能在 2035 年前爆發</li>
<li>股票市場指數是什麼，如何使用它們？</li>
<li>安海斯布希收購 BeatBox 以吸引年輕飲酒者</li>
</ul>
<p><strong>想看看其他對 RVTY 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com 獲取 Revvity Inc.（NYSE:RVTY - 免費報告）的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 $1,000 在 Revvity 嗎？</h2>
<p>在考慮 Revvity 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Revvity 並不在名單上。</p>
<p>雖然 Revvity 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

RVTY

<p>Federated Hermes Inc. 在第二季度減少了對 Revvity Inc. 的持股，降幅為 9.5%，目前持有 213,182 股，市值為 2060 萬美元。其他投資者也調整了持倉，機構持有 Revvity 的比例為 86.65%。分析師的評級意見不一，普遍維持 “持有” 評級，平均目標價為 113.08 美元。Revvity 的股票開盤價為 98.85 美元，市值為 112.1 億美元。公司報告第三季度每股收益為 1.18 美元，超出預期。宣佈每股季度分紅為 0.07 美元</p>

<p>Federated Hermes Inc. lowered its stake in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 9.5% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 213,182 shares of the company's stock after selling 22,482 shares during the period. Federated Hermes Inc. owned about 0.18% of Revvity worth $20,619,000 as of its most recent filing with the Securities and Exchange Commission.</p>
<div class="lb-trans"><p>根據公司在最近向證券交易委員會的披露，Federated Hermes Inc. 在第二季度將其在 Revvity Inc.（紐約證券交易所代碼：RVTY - 免費報告）中的股份減少了 9.5%。該機構投資者在此期間出售了 22,482 股後，持有 213,182 股該公司的股票。截至其最近向證券交易委員會的備案，Federated Hermes Inc. 持有 Revvity 約 0.18% 的股份，價值 20,619,000 美元。</p>
</div><p>Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd increased its holdings in Revvity by 25.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 694 shares of the company's stock valued at $73,000 after buying an additional 140 shares in the last quarter. Banque Transatlantique SA grew its holdings in shares of Revvity by 19.4% in the 1st quarter. Banque Transatlantique SA now owns 925 shares of the company's stock worth $90,000 after acquiring an additional 150 shares during the period. CVA Family Office LLC increased its stake in Revvity by 79.0% in the 2nd quarter. CVA Family Office LLC now owns 410 shares of the company's stock valued at $40,000 after purchasing an additional 181 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in Revvity by 25.9% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 900 shares of the company's stock valued at $87,000 after purchasing an additional 185 shares in the last quarter. Finally, Leslie Global Wealth LLC raised its holdings in Revvity by 9.3% during the second quarter. Leslie Global Wealth LLC now owns 2,195 shares of the company's stock worth $212,000 after purchasing an additional 186 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他機構投資者和對沖基金最近也增加或減少了對該公司的持股。凱通國際資產管理有限公司在第一季度將其在 Revvity 的持股增加了 25.3%。凱通國際資產管理有限公司目前持有 694 股該公司的股票，價值 73,000 美元，此前在上個季度又購買了 140 股。跨大西洋銀行在第一季度將其在 Revvity 的持股增加了 19.4%。跨大西洋銀行目前持有 925 股該公司的股票，價值 90,000 美元，此前在此期間又收購了 150 股。CVA Family Office LLC 在第二季度將其在 Revvity 的持股增加了 79.0%。CVA Family Office LLC 目前持有 410 股該公司的股票，價值 40,000 美元，此前在上個季度又購買了 181 股。EverSource Wealth Advisors LLC 在第二季度將其在 Revvity 的持股增加了 25.9%。EverSource Wealth Advisors LLC 目前持有 900 股該公司的股票，價值 87,000 美元，此前在上個季度又購買了 185 股。最後，Leslie Global Wealth LLC 在第二季度將其在 Revvity 的持股增加了 9.3%。Leslie Global Wealth LLC 目前持有 2,195 股該公司的股票，價值 212,000 美元，此前在上個季度又購買了 186 股。目前 86.65% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師評級調整</h2>
</div><p>Several research firms have weighed in on RVTY. Barclays upped their target price on Revvity from $100.00 to $105.00 and gave the company an &#34;overweight&#34; rating in a report on Tuesday, October 28th. Weiss Ratings reissued a &#34;sell (d)&#34; rating on shares of Revvity in a research note on Monday. Bank of America cut their target price on shares of Revvity from $110.00 to $99.00 and set a &#34;buy&#34; rating for the company in a research report on Monday, September 22nd. Robert W. Baird increased their price target on shares of Revvity from $122.00 to $123.00 and gave the company an &#34;outperform&#34; rating in a research report on Tuesday, October 28th. Finally, Evercore ISI reissued an &#34;outperform&#34; rating and set a $108.00 price objective on shares of Revvity in a research note on Monday, October 27th. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of &#34;Hold&#34; and an average price target of $113.08.</p>
<div class="lb-trans"><p>幾家研究公司對 RVTY 發表了看法。巴克萊將 Revvity 的目標價格從 100.00 美元上調至 105.00 美元，並在 10 月 28 日的報告中給予該公司 “超配” 評級。Weiss Ratings 在週一的研究報告中重新發布了對 Revvity 股票的 “賣出（d）” 評級。美國銀行在 9 月 22 日的研究報告中將 Revvity 的目標價格從 110.00 美元下調至 99.00 美元，併為該公司設定了 “買入” 評級。羅伯特·W·貝爾德在 10 月 28 日的研究報告中將 Revvity 的目標價格從 122.00 美元上調至 123.00 美元，並給予該公司 “跑贏大盤” 評級。最後，Evercore ISI 在 10 月 27 日的研究報告中重新發布了 “跑贏大盤” 評級，併為 Revvity 設定了 108.00 美元的目標價格。七位股票研究分析師對該股票給予了買入評級，六位給予了持有評級，一位給予了賣出評級。根據 MarketBeat.com 的數據，該公司的共識評級為 “持有”，平均目標價格為 113.08 美元。</p>
</div><p><strong>View Our Latest Stock Analysis on RVTY</strong></p>
<div class="lb-trans"><p><strong>查看我們最新的 RVTY 股票分析</strong></p>
</div><h2>Revvity Price Performance</h2>
<div class="lb-trans"><h2>Revvity 價格表現</h2>
</div><p>Revvity stock opened at $98.85 on Wednesday. The stock has a market capitalization of $11.21 billion, a P/E ratio of 49.67, a P/E/G ratio of 3.30 and a beta of 1.06. Revvity Inc. has a 12-month low of $81.36 and a 12-month high of $128.29. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.75 and a quick ratio of 1.44. The firm's 50-day moving average is $95.54 and its two-hundred day moving average is $93.12.</p>
<div class="lb-trans"><p>Revvity 股票在週三開盤價為 98.85 美元。該公司的市值為 112.1 億美元，市盈率為 49.67，市盈增長比率為 3.30，貝塔值為 1.06。Revvity Inc.的 12 個月最低價為 81.36 美元，最高價為 128.29 美元。該公司的債務與股本比率為 0.36，流動比率為 1.75，速動比率為 1.44。該公司的 50 日移動平均線為 95.54 美元，200 日移動平均線為 93.12 美元。</p>
</div><p>Revvity (NYSE:RVTY - Get Free Report) last posted its quarterly earnings data on Monday, October 27th. The company reported $1.18 earnings per share for the quarter, beating analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 8.44% and a return on equity of 7.52%. The business had revenue of $698.95 million during the quarter, compared to analyst estimates of $699.75 million. During the same quarter in the previous year, the business posted $1.28 earnings per share. The company's revenue was up 2.2% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.900-5.000 EPS. Equities analysts predict that Revvity Inc. will post 4.94 earnings per share for the current year.</p>
<div class="lb-trans"><p>Revvity（紐約證券交易所代碼：RVTY - 獲取免費報告）最近在 10 月 27 日發佈了季度財報。該公司報告本季度每股收益為 1.18 美元，超出分析師共識預期的 1.14 美元，超出幅度為 0.04 美元。Revvity 的淨利潤率為 8.44%，股本回報率為 7.52%。該公司在本季度的收入為 6.9895 億美元，而分析師預期為 6.9975 億美元。在去年同期，該公司每股收益為 1.28 美元。該公司的收入同比增長了 2.2%。Revvity 已將其 2025 財年的指導目標設定為 4.900-5.000 每股收益。股票分析師預測 Revvity Inc.在當前年度將發佈 4.94 美元的每股收益。</p>
</div><h2>Revvity Dividend Announcement</h2>
<div class="lb-trans"><h2>Revvity 股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 6th. Stockholders of record on Friday, January 16th will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, January 16th. This represents a $0.28 annualized dividend and a dividend yield of 0.3%. Revvity's dividend payout ratio (DPR) is 14.07%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度股息，將於 2 月 6 日（星期五）支付。1 月 16 日（星期五）登記的股東將獲得每股 0.07 美元的股息。除息日期為 1 月 16 日（星期五）。這代表着每年 0.28 美元的股息和 0.3% 的股息收益率。Revvity 的股息支付比率（DPR）為 14.07%。</p>
</div><p>Revvity declared that its board has approved a stock buyback plan on Monday, October 27th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase up to 8.7% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's management believes its stock is undervalued.</p>
<div class="lb-trans"><p>Revvity 宣佈其董事會已於 10 月 27 日批准了一項股票回購計劃，允許公司回購 10 億美元的股票。該回購授權允許公司通過公開市場購買最多 8.7% 的股票。股票回購計劃通常表明公司的管理層認為其股票被低估。</p>
</div><h2>Revvity Company Profile</h2>
<div class="lb-trans"><h2>Revvity 公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.</p>
<div class="lb-trans"><p>Revvity, Inc.在美洲、歐洲和亞洲及國際上提供健康科學解決方案、技術和服務。生命科學部門提供儀器、試劑、信息學、軟件、訂閲、檢測、成像技術、保修、培訓和服務。其診斷部門提供儀器、試劑、檢測平台和軟件產品，用於早期檢測遺傳疾病，如妊娠和早期兒童疾病，以及在診斷市場中的傳染病檢測。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>特色文章</h2>
</div><ul>
<li>Five stocks we like better than Revvity</li>
<li>Growth Stocks: What They Are, Examples and How to Invest</li>
<li>Consumers Got Coal, But Santa Dropped Off Big Gains for These 2 Retailers</li>
<li>What is diluted earnings per share (Diluted EPS)?</li>
<li>10X Gains? These 3 Robotics Stocks Could Explode by 2035</li>
<li>What is a Stock Market Index and How Do You Use Them?</li>
<li>Anheuser-Busch Buys BeatBox to Win Over Younger Drinkers</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Revvity 更好</li>
<li>成長股：它們是什麼，例子以及如何投資</li>
<li>消費者得到了煤炭，但聖誕老人給這兩家零售商帶來了巨大的收益</li>
<li>稀釋每股收益（Diluted EPS）是什麼？</li>
<li>10 倍收益？這三隻機器人股票可能在 2035 年前爆發</li>
<li>股票市場指數是什麼，如何使用它們？</li>
<li>安海斯布希收購 BeatBox 以吸引年輕飲酒者</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding RVTY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Revvity Inc. (NYSE:RVTY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對 RVTY 感興趣的對沖基金持有哪些股票嗎？</strong> 訪問 HoldingsChannel.com 獲取 Revvity Inc.（NYSE:RVTY - 免費報告）的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVJWVFk" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=RVTY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Revvity Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 $1,000 在 Revvity 嗎？</h2>
</div><p>Before you consider Revvity, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Revvity 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Revvity wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Revvity 並不在名單上。</p>
</div><p>While Revvity currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Revvity 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Federated Hermes Inc. 減持了其在 Revvity Inc. $RVTY 的持倉